share_log

'Lawmakers Push To Let Telehealth Providers Keep Prescribing Stimulants And Addiction Treatment; Flexibility Allowed During Pandemic Is Set To Expire At Year-End' - STAT News

'Lawmakers Push To Let Telehealth Providers Keep Prescribing Stimulants And Addiction Treatment; Flexibility Allowed During Pandemic Is Set To Expire At Year-End' - STAT News

立法者們推動讓遠程醫療服務提供者繼續開具興奮劑和戒癮治療藥物處方;疫情期間允許靈活性將於年底到期 - STAt資訊
Benzinga ·  09/24 10:17

Two Democratic lawmakers are working to preserve health providers' right to prescribe controlled substances via telehealth, including stimulants for ADHD and buprenorphine for opioid addiction.

兩名民主黨議員正在努力維護健康服務提供者通過遠程醫療處方受控物質的權利,包括用於ADHD的興奮劑和用於阿片類藥物成癮的丁丙諾啡。

A new bill being drafted by Sen. Mark Warner (D-Va.) and Rep. Doris Matsui (D-Calif.) comes months before the expiration of temporary waivers first enacted by the Drug Enforcement Administration's during the Covid-19 pandemic. Though the DEA is currently contemplating new regulations that would roll back many of the pandemic-era flexibilities, the lawmakers' new bill would likely extend the current rules through 2026, according to two lobbyists familiar with the effort.

弗吉尼亞州參議員馬克·沃納(D-Va.)和加利福尼亞州衆議員多麗絲·馬茨伊(D-Calif.)正草擬的新法案早在美國禁毒局在新冠疫情期間首次頒佈臨時豁免到期之前數月即已開始。儘管美國禁毒局目前正在考慮新的規定,這些規定可能會取消許多疫情期間的靈活性,但議員們的新法案可能會延長當前的規定至2026年,根據兩名熟悉該工作的遊說者。

The flexible rules are set to expire at the end of the year, which telehealth advocates say could threaten patient access to medications, including stimulants for ADHD and common medications used to treat opioid addiction.

靈活的規定定於年底到期,遠程醫療倡導者表示可能會威脅患者獲得藥物的途徑,其中包括用於ADHD的興奮劑和常用於治療阿片類藥物成癮的藥物。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論